Terms: = Breast cancer AND FANCG, ENSG00000221829, 2189, O15287, XRCC9, FAG AND Treatment
10 results:
1. Performance, clinical utility, and cost-effectiveness of selective use of staging investigations in early breast cancers.
James J; Teo M; Ramachandran V; Law M; Cheng M
ANZ J Surg; 2022 Mar; 92(3):426-430. PubMed ID: 34723441
[TBL] [Abstract] [Full Text] [Related]
2. Quality indicators for breast cancer care: A systematic review.
Maes-Carballo M; Gómez-Fandiño Y; Reinoso-Hermida A; Estrada-López CR; Martín-Díaz M; Khan KS; Bueno-Cavanillas A
Breast; 2021 Oct; 59():221-231. PubMed ID: 34298301
[TBL] [Abstract] [Full Text] [Related]
3. Impaired retinal pigment epithelium in paclitaxel-induced macular edema: A case report.
Shih CH; Lee YC
Medicine (Baltimore); 2018 Jun; 97(26):e11229. PubMed ID: 29952984
[TBL] [Abstract] [Full Text] [Related]
4. Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.
Sedlmayer F; Zehentmayr F; Fastner G
Breast; 2013 Aug; 22 Suppl 2():S141-6. PubMed ID: 24074775
[TBL] [Abstract] [Full Text] [Related]
5. Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.
Vickers MR; MacLennan AH; Lawton B; Ford D; Martin J; Meredith SK; DeStavola BL; Rose S; Dowell A; Wilkes HC; Darbyshire JH; Meade TW;
BMJ; 2007 Aug; 335(7613):239. PubMed ID: 17626056
[TBL] [Abstract] [Full Text] [Related]
6. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract] [Full Text] [Related]
7. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract] [Full Text] [Related]
8. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways.
Hussain S; Wilson JB; Medhurst AL; Hejna J; Witt E; Ananth S; Davies A; Masson JY; Moses R; West SC; de Winter JP; Ashworth A; Jones NJ; Mathew CG
Hum Mol Genet; 2004 Jun; 13(12):1241-8. PubMed ID: 15115758
[TBL] [Abstract] [Full Text] [Related]
9. Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States).
Li CI; Rossing MA; Voigt LF; Daling JR
Cancer Causes Control; 2000 Oct; 11(9):805-11. PubMed ID: 11075869
[TBL] [Abstract] [Full Text] [Related]
10. [Relation of tumor size, lymph node status and prognosis in breast cancer].
Shen ZZ
Zhonghua Wai Ke Za Zhi; 1991 Sep; 29(9):554-7, 589. PubMed ID: 1813258
[TBL] [Abstract] [Full Text] [Related]
